Abstract
Biodiesel is an alkyl ester of long chain fatty acids and is considered to leave smaller footprint on the environment. It is produced by transesterification of a fat/oil with a short chain primary alcohol like methanol or ethanol. The three routes to its preparation are: alkali catalyzed, acid catalyzed and lipase-catalyzed transesterification. This review summarizes the key patents filed over the last few decades. The chemistry used in these patents is one of the three routes mentioned above. In few patents, heterogeneous catalysts have been used for catalyzing the transesterification process. The innovations mostly concern fine-tuning of the reaction conditions, plant design to improve logistics and use of glycerol produced as a by-product during biodiesel production. There is a concern that biofuels like biodiesel cut into resources like land meant for food crop production. Life cycle studies also create doubt about there being energy efficient fuels. Judicious choices that would differ with different regions are recommended. For the next few decades till better alternatives like hydrogen become viable, biodiesel would continue to be an important “alternative fuel”.
Keywords: Biodiesel, biofuels, biorefinery, enzymes in low water media, enzymes in organic solvents, esterification, fatty acid esters, fatty acid ethyl esters, fatty acid methyl esters, lipases
Recent Patents on Biotechnology
Title: Process Optimization for Biodiesel Production
Volume: 2 Issue: 2
Author(s): Veena Singh, Kusum Solanki and Munishwar N. Gupta
Affiliation:
Keywords: Biodiesel, biofuels, biorefinery, enzymes in low water media, enzymes in organic solvents, esterification, fatty acid esters, fatty acid ethyl esters, fatty acid methyl esters, lipases
Abstract: Biodiesel is an alkyl ester of long chain fatty acids and is considered to leave smaller footprint on the environment. It is produced by transesterification of a fat/oil with a short chain primary alcohol like methanol or ethanol. The three routes to its preparation are: alkali catalyzed, acid catalyzed and lipase-catalyzed transesterification. This review summarizes the key patents filed over the last few decades. The chemistry used in these patents is one of the three routes mentioned above. In few patents, heterogeneous catalysts have been used for catalyzing the transesterification process. The innovations mostly concern fine-tuning of the reaction conditions, plant design to improve logistics and use of glycerol produced as a by-product during biodiesel production. There is a concern that biofuels like biodiesel cut into resources like land meant for food crop production. Life cycle studies also create doubt about there being energy efficient fuels. Judicious choices that would differ with different regions are recommended. For the next few decades till better alternatives like hydrogen become viable, biodiesel would continue to be an important “alternative fuel”.
Export Options
About this article
Cite this article as:
Singh Veena, Solanki Kusum and Gupta N. Munishwar, Process Optimization for Biodiesel Production, Recent Patents on Biotechnology 2008; 2 (2) . https://dx.doi.org/10.2174/187220808784619748
DOI https://dx.doi.org/10.2174/187220808784619748 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Amino Acid Degrading Enzymes and their Application in Cancer Therapy
Current Medicinal Chemistry Clearance of Amyloid-β Peptide Across the Blood-Brain Barrier: Implication for Therapies in Alzheimers Disease
CNS & Neurological Disorders - Drug Targets CXCR7 Participates in CXCL12-mediated Cell Cycle and Proliferation Regulation in Mouse Neural Progenitor Cells
Current Molecular Medicine Targeting Interleukin-21 in Immune-Mediated Pathologies
Current Drug Targets Meet Our Editorial Board Member
Current Medicinal Chemistry Chemometric Modeling of 5-Phenylthiophenecarboxylic Acid Derivatives as Anti-Rheumatic Agents
Current Computer-Aided Drug Design Structure-Activity Relationships in Peptide-Antibody Complexes: Implications for Epitope Prediction and Development of Synthetic Peptide Vaccines
Current Medicinal Chemistry Small Molecular Inhibitors of p-STAT3: Novel Agents for Treatment of Primary and Metastatic CNS Cancers
Recent Patents on CNS Drug Discovery (Discontinued) Prevention of Colitis-associated Cancer: Natural Compounds that Target the IL-6 Soluble Receptor
Anti-Cancer Agents in Medicinal Chemistry Mitochondrial Oxidative Stress and Heart Failure ∼Novel Pathophysiological Insight and Treatment Strategies∼
Current Cardiology Reviews L-Asparaginase and Inhibitors of Glutamine Synthetase Disclose Glutamine Addiction of β-Catenin-Mutated Human Hepatocellular Carcinoma Cells
Current Cancer Drug Targets Synthesis of Some New 1(2H)-Phthalazinone Derivatives and Evaluation of Their Acetylcholinesterase and Butyrylcholinesterase Inhibitory Activities
Letters in Drug Design & Discovery Propofol in Anesthesia. Mechanism of Action, Structure-Activity Relationships, and Drug Delivery
Current Medicinal Chemistry Medical Marijuana Use and Parenting: A Qualitative Study
Adolescent Psychiatry Cerebrovascular Profile Assessment in Parkinson's Disease Patients
CNS & Neurological Disorders - Drug Targets Kinase Inhibitors as Potential Therapeutics for Acute and Chronic Neurodegenerative Conditions
Current Pharmaceutical Design Effects of Secondhand Smoke on Thyroid Function
Inflammation & Allergy - Drug Targets (Discontinued) Comparison of Luminescence ADP Production Assay and Radiometric Scintillation Proximity Assay for Cdc7 Kinase
Combinatorial Chemistry & High Throughput Screening Growth Factor Therapy in Atherosclerotic Disease-Friend or Foe
Current Pharmaceutical Design Treatment of Chronic Migraine with Intramuscular Pericranial Injections of Onabotulinumtoxin A
Recent Patents on CNS Drug Discovery (Discontinued)